401 filings
Page 13 of 21
8-K
mii7jhxci919em0x35la
3 Feb 04
Genome Therapeutics Sets Price of Common Stock Offering
12:00am
8-K
kvukj3w zq82lu
3 Feb 04
Genome Therapeutics Sets Price of Common Stock Offering
12:00am
424B4
m03l24sklf
3 Feb 04
Prospectus supplement with pricing info
12:00am
425
om63ggdigefjnyo ox
2 Feb 04
Business combination disclosure
12:00am
S-3MEF
s8192821b
2 Feb 04
Registration of additional securities for an S-3
12:00am
8-K
bcvxv
2 Feb 04
Genome Therapeutics Reports on Nasdaq Interpretation
12:00am
8-K/A
tc80 24nqx8u
30 Jan 04
Other events
12:00am
DEFA14A
pb7jxinucklgu
16 Jan 04
Additional proxy soliciting materials
12:00am
8-K
nqinrvl rjmxa8scgw
9 Jan 04
Genome Therapeutics and Amgen Conclude Research Agreement; Genome Therapeutics
12:00am
425
x4yax57tp jc51xbg0c
9 Jan 04
Business combination disclosure
12:00am
425
0jln0gy ja3
9 Jan 04
Business combination disclosure
12:00am
8-K
1jjxfjct
9 Jan 04
Genome Therapeutics Enters Agreement to TransferStreptococcus pneumoniae Patent Portfolio to Aventis
12:00am
425
gso1iec2 jy97ja444
31 Dec 03
Business combination disclosure
12:00am
8-K
yu1uns
31 Dec 03
Other events
12:00am
S-4/A
znz8tk3rnbh42 z2qi5c
30 Dec 03
Registration of securities issued in business combination transactions (amended)
12:00am
8-K
32ohp876zzu3
18 Dec 03
Other events
12:00am
425
k9x9xpl2d4i3a4qae7
18 Dec 03
Business combination disclosure
12:00am
8-K
57nahqqtc 85f
17 Dec 03
Other events
12:00am